Clinical Application of A New In Vitro High-throughput Drug Sensitivity Screening Technology in Individualized Medication of Relapsed Refractory Acute Myeloid Leukemia Patients

Clinical Application of A New In Vitro High-throughput Drug Sensitivity Screening Technology in Individualized Medication of Relapsed Refractory Acute Myeloid Leukemia Patients

Objective To explore the clinical value of new high-throughput drug sensitivity (HDS) screening technology in the individualized medication of relapsed refractory acute myeloid leukemia patients. Methods We collected bone marrow samples of 19 patients with relapsed and refractory acute myeloid leuke...

Full description

Bibliographic Details
Main Authors: WU Haibing, ZHAO Xiaoyan, SHEN Mingfang, Huang Rui, CHEN Cheng, REN Tao, SHEN Yang
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2020-06-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
drug sensitivity
aml
high-throughput
hds
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1364.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1364.htm

Similar Items